logo
  

Stora Enso Q1 Results Down; Warns On Q2 Profit, Confirms FY24 Outlook

Stora Enso Oyj (SEOAY.PK), a Finnish paper mill company, reported Thursday that its first-quarter net result plunged 54.5 percent to 84 million euros from last year's 185 million euros.

Earnings per share were 0.11 euro, down 55.2 percent from last year's 0.24 euro. Adjusted earnings per share were 0.09 euro, compared to last year's 0.23 euro.

Adjusted EBIT decreased 33.1 percent from last year to 156 million euros. Adjusted EBIT margin was 7.2 percent, down from prior year's 8.6 percent.

Sales decreased 20 percent to 2.16 billion euros from last year's 2.72 billion euros.

Looking ahead, the company said profits are expected to be adversely impacted in the second quarter, mainly due to the sequentially higher maintenance costs in the quarter, higher wood costs, and the recent political strikes in Finland.

However, the firm is on track and committed to meet full year 2024 adjusted EBIT guidance to be higher than the full year 2023 adjusted EBIT of 342 million euro.

Stora Enso anticipates a gradual recovery in market conditions in 2024, with increased demand for consumer board, higher pulp demand and prices.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AbbVie (ABBV) Monday announced a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals, a clinical stage neuroscience biotech firm, to develop next-generation treatment approaches and unmet needs in psychiatric disorders. AbbVie noted that the first-generation compounds may... Healthwest Minerals, Inc. d/b/a Mt. Capra Products has recalled 1,506 boxes of Goat Milk Formula Recipe Kit, also urging consumers to immediately discontinue use of the product as infant formula. The firm does not recommend using this product for infants from 0-12 months of age. Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT